Daniel I. Brierley

2.1k total citations · 2 hit papers
16 papers, 1.5k citations indexed

About

Daniel I. Brierley is a scholar working on Cellular and Molecular Neuroscience, Pharmacology and Endocrine and Autonomic Systems. According to data from OpenAlex, Daniel I. Brierley has authored 16 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cellular and Molecular Neuroscience, 6 papers in Pharmacology and 5 papers in Endocrine and Autonomic Systems. Recurrent topics in Daniel I. Brierley's work include Diabetes Treatment and Management (5 papers), Cannabis and Cannabinoid Research (5 papers) and Regulation of Appetite and Obesity (5 papers). Daniel I. Brierley is often cited by papers focused on Diabetes Treatment and Management (5 papers), Cannabis and Cannabinoid Research (5 papers) and Regulation of Appetite and Obesity (5 papers). Daniel I. Brierley collaborates with scholars based in United Kingdom, United States and Switzerland. Daniel I. Brierley's co-authors include Mark A. Ungless, Frédéric Brischoux, Subhojit Chakraborty, Stefan Trapp, Colin Davidson, Guillaume de Lartigue, Frank Reimann, Marie K. Holt, Fiona M. Gribble and Benjamin J. Whalley and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Diabetes and The Journal of Comparative Neurology.

In The Last Decade

Daniel I. Brierley

16 papers receiving 1.4k citations

Hit Papers

Phasic excitation of dopamine neurons in ventral VTA by n... 2009 2026 2014 2020 2009 2021 200 400 600

Peers

Daniel I. Brierley
David J. Reiner United States
Steven P. Vickers United Kingdom
Morgane Thomsen United States
Melissa A. Herman United States
Michal Bajo United States
Marsida Kallupi United States
Arnauld Belmer Australia
Daniel I. Brierley
Citations per year, relative to Daniel I. Brierley Daniel I. Brierley (= 1×) peers Pia Steensland

Countries citing papers authored by Daniel I. Brierley

Since Specialization
Citations

This map shows the geographic impact of Daniel I. Brierley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel I. Brierley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel I. Brierley more than expected).

Fields of papers citing papers by Daniel I. Brierley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel I. Brierley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel I. Brierley. The network helps show where Daniel I. Brierley may publish in the future.

Co-authorship network of co-authors of Daniel I. Brierley

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel I. Brierley. A scholar is included among the top collaborators of Daniel I. Brierley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel I. Brierley. Daniel I. Brierley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Jones, Lauren A. & Daniel I. Brierley. (2025). GLP-1 and the Neurobiology of Eating Control: Recent Advances. Endocrinology. 166(2). 11 indexed citations
2.
Brierley, Daniel I., Brian Lam, Georgina K.C. Dowsett, et al.. (2022). Obesity medication lorcaserin activates brainstem GLP-1 neurons to reduce food intake and augments GLP-1 receptor agonist induced appetite suppression. Molecular Metabolism. 68. 101665–101665. 21 indexed citations
3.
Brierley, Daniel I., Marie K. Holt, Arashdeep Singh, et al.. (2021). Central and peripheral GLP-1 systems independently suppress eating. Nature Metabolism. 3(2). 258–273. 180 indexed citations breakdown →
4.
Trapp, Stefan & Daniel I. Brierley. (2021). Brain GLP‐1 and the regulation of food intake: GLP‐1 action in the brain and its implications for GLP‐1 receptor agonists in obesity treatment. British Journal of Pharmacology. 179(4). 557–570. 92 indexed citations
5.
Brierley, Daniel I. & Guillaume de Lartigue. (2021). Reappraising the role of the vagus nerve in GLP‐1‐mediated regulation of eating. British Journal of Pharmacology. 179(4). 584–599. 48 indexed citations
6.
Holt, Marie K., Daniel I. Brierley, James E. Richards, et al.. (2020). PPG neurons in the nucleus of the solitary tract modulate heart rate but do not mediate GLP-1 receptor agonist-induced tachycardia in mice. Molecular Metabolism. 39. 101024–101024. 24 indexed citations
7.
Brierley, Daniel I., Joe Harman, Natasa Giallourou, et al.. (2019). Chemotherapy‐induced cachexia dysregulates hypothalamic and systemic lipoamines and is attenuated by cannabigerol. Journal of Cachexia Sarcopenia and Muscle. 10(4). 844–859. 40 indexed citations
8.
Holt, Marie K., James E. Richards, Daniel I. Brierley, et al.. (2018). Preproglucagon Neurons in the Nucleus of the Solitary Tract Are the Main Source of Brain GLP-1, Mediate Stress-Induced Hypophagia, and Limit Unusually Large Intakes of Food. Diabetes. 68(1). 21–33. 152 indexed citations
9.
Card, J. Patrick, Ida J. Llewellyn‐Smith, Huiyuan Zheng, et al.. (2018). GLP‐1 neurons form a local synaptic circuit within the rodent nucleus of the solitary tract. The Journal of Comparative Neurology. 526(14). 2149–2164. 33 indexed citations
10.
Brierley, Daniel I., et al.. (2017). A cannabigerol-rich Cannabis sativa extract, devoid of ∆9-tetrahydrocannabinol, elicits hyperphagia in rats. Behavioural Pharmacology. 28(4). 280–284. 26 indexed citations
11.
Brierley, Daniel I., et al.. (2016). Cannabigerol is a novel, well-tolerated appetite stimulant in pre-satiated rats. Psychopharmacology. 233(19-20). 3603–3613. 54 indexed citations
12.
13.
Brierley, Daniel I. & Colin Davidson. (2012). Developments in harmine pharmacology — Implications for ayahuasca use and drug-dependence treatment. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 39(2). 263–272. 100 indexed citations
14.
Brierley, Daniel I. & Colin Davidson. (2012). Harmine augments electrically evoked dopamine efflux in the nucleus accumbens shell. Journal of Psychopharmacology. 27(1). 98–108. 29 indexed citations
15.
Brischoux, Frédéric, Subhojit Chakraborty, Daniel I. Brierley, & Mark A. Ungless. (2009). Phasic excitation of dopamine neurons in ventral VTA by noxious stimuli. Proceedings of the National Academy of Sciences. 106(12). 4894–4899. 631 indexed citations breakdown →
16.
Schweimer, Judith, Daniel I. Brierley, & Mark A. Ungless. (2008). Phasic nociceptive responses in dorsal raphe serotonin neurons. Fundamental and Clinical Pharmacology. 22. 119–119. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026